-
421
Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study)
Published 2022-07-01“…Introduction A substantial proportion of individuals infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), report persisting symptoms weeks and months following acute infection. …”
Get full text
Article -
422
Computational Study of the Phytochemical Constituents from Uncaria tomentosa Stem Bark against SARS-CoV-2 Omicron Spike Protein
Published 2022-01-01“…The SARS-CoV-2 Omicron variant has spread rapidly and is considered the predominant variant in the world, and its main characteristic is related to evade immunity from natural infection or vaccines, due to its multiple mutations in the spike protein. …”
Get full text
Article -
423
-
424
Assessing the impact of drought on Zlatar Lake area changes using Random Forest with Sentinel-1 SAR and Sentinel-2 multispectral data
Published 2024-01-01Subjects: Get full text
Article -
425
Correlation of the cycle threshold value of SARS-CoV-2 by RT-PCR with biomarker levels in the prognosis of patients hospitalized with COVID-19
Published 2025-01-01“…Background and Objective: The COVID-19 disease caused by SARS-CoV-2 was declared as pandemic by WHO soon after its emergence in 2019. …”
Get full text
Article -
426
Clinical Performance of Rapid Antigen Tests for the Detection of SARS-CoV-2 Infection in the Emergency Department and Community: A Retrospective Study
Published 2022-01-01“…Rapid antigen tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection have been authorized for emergency use (EUA); however, the performance has not been fully evaluated in clinical contexts. …”
Get full text
Article -
427
Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron BA variants
Published 2025-01-01“…Results Across the whole population, MVB.1.351 vaccine induces highest NAbs titers against Omicron BA.1 and BA.4/5 variants at D28 and M3 post-booster. In participants with SARS-CoV-2 infection between D28 and M3, both MVB.1.351 and BNT162b2 vaccine groups show an increase in GMTs against Omicron BA.1 and Omicron BA.4/5 following infection. …”
Get full text
Article -
428
Immune Thrombocytopenic Purpura following Administration of mRNA-Based SARS-CoV-2 and MMR Vaccinations: A Cautionary Tale
Published 2021-01-01“…Although our patient’s clinical presentation and subsequent course are similar to those of other cases of ITP in association with SARS-CoV-2 vaccination, to our knowledge, this is the first reported case of ITP following MMR and mRNA SARS-CoV-2 vaccine coadministration. …”
Get full text
Article -
429
Inhibition of the SARS-CoV-2 Main Protease by Isoquercitrin γ-Cyclodextrin Inclusion Complex Formulations: A Biochemical and In Silico Study
Published 2023-01-01“…The main protease (Mpro) of SARS-CoV-2 is a well-established drug target for rational drug design of COVID-19 inhibitors. …”
Get full text
Article -
430
SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city.
Published 2021-01-01“…The study aim was to describe SARS-CoV-2 pneumonia and cut-offs for defining long COVID in primary care follow-up patients.…”
Get full text
Article -
431
Fast and Sensitive Detection of SARS-CoV-2 Nucleic Acid Using a Rapid Detection System Free of RNA Extraction
Published 2023-01-01“…To establish and evaluate the analytical and clinical performance of the Flash20 SARS-CoV-2 nucleic acid rapid detection system free of RNA extraction. …”
Get full text
Article -
432
Computer-Aided Analysis of Multiple SARS-CoV-2 Therapeutic Targets: Identification of Potent Molecules from African Medicinal Plants
Published 2020-01-01“…In this study, molecules from African medicinal plants were analysed as potential candidates against multiple SARS-CoV-2 therapeutic targets. Sixty-five molecules from the ZINC database subset (AfroDb Natural Products) were virtually screened with some reported repurposed therapeutics against six SARS-CoV-2 and two human targets. …”
Get full text
Article -
433
SARS-CoV-2 SPIKE Antibody Levels can Indicate Immuno-Resilience to Re-infection: a Real-World Study
Published 2024-12-01Subjects: Get full text
Article -
434
A method for monitoring three dimensional surface deformation in mining areas combining SBAS-InSAR, GNSS and probability integral method
Published 2025-01-01Subjects: Get full text
Article -
435
Proceso del cuidado enfermero aplicado en adulto con síndrome de distrés respiratorio por SARS-CoV-2
Published 2023-02-01“… Brindar un cuidado especializado de enfermería enfocado en minimizar las complicaciones en un paciente crítico con síndrome de distrés respiratorio por SARS-CoV-2 en la Unidad de Cuidados Intensivos. Caso clínico: Paciente de 43 años de sexo masculino con síndrome de distrés respiratorio por SARS-CoV-2, choque séptico a foco pulmonar y falla renal aguda; ingresado a la Unidad de Cuidados Intensivos Adulto del Hospital del Norte, al momento bajo sedoanalgesia con RASS -4, monitorizado, se encuentra orointubado, bajo ventilación mecánica, secreción bronquial mucupurulenta en gran cantidad a la aspiración, al momento 18 horas en posición prona. …”
Get full text
Article -
436
Transcriptomic profiles of monocyte-derived macrophages exposed to SARS-CoV-2 VOCs reveal immune-evasion escape driven by delta
Published 2025-02-01“…Abstract Background Since the breakout of COVID-19, the mutated forms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have shown enhanced rates of transmission and adaptation to humans. …”
Get full text
Article -
437
Medicinal plants with anti-SARS-CoV activity repurposing for treatment of COVID-19 infection: A systematic review and meta-analysis
Published 2022-06-01“…This study investigates the practicality of some medicinal plants for SARS-CoV-2 therapy using a systematic review and meta-analysis of their reported SARS-CoV-1 inhibitory potencies. …”
Get full text
Article -
438
Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants
Published 2025-01-01Subjects: Get full text
Article -
439
The Frequency Of Hematological Abnormalities in Children (Age 1 Month To 12 Years) Presenting With Sars-Cov-2 Infection At Shifa International Hospital
Published 2024-03-01“…Keywords: COVID-19, Hematological abnormalities, Neutropenia, SARS-COV-2 infection. …”
Get full text
Article -
440
Türkiye'de Bir Çocuk Acil Servisindeki COVID-19 Tanılı Çocukların Klinik Özellikleri
Published 2021-12-01Subjects: Get full text
Article